explore -WSS

explore

author：Wikipedia 2025-10-02 01:08:30 - browse：856

Cambridge: Biogen — Ruby Wallau for STAT

Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person group focused on using new types of data like those from mobile phones and smart watches, and ending a clinical trial being conducted with Apple early, STAT has learned.

Biogen confirmed the organizational change, but said it might lean even more on digital tech startups in the future.

“It’s certainly not an abandonment of digital, it’s more of a realignment of resources and priorities,” said Adam Keeney, Biogen’s executive vice president and head of corporate development. However, he later acknowledged, Biogen Digital Health, a separate entity, “would no longer continue in its current form.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： How the BIOSECURE Act is already affecting U.S., Chinese life science firms

WSS

Device maker Teleflex to acquire urology company for $600M

Moderna says combo Covid

Roche’s Alnylam deal shows drug firms interested in heart drugs

Why patients can’t get everything they want on drug pricing

How faith leaders like me can help address America's obesity epidemic

CDC Director Mandy Cohen on transparency, trust, and health

entertainment

explore

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

A new crop of companies is reshaping the health data economy

New air purifier tech could be key to improving indoor air quality

A new crop of companies is reshaping the health data economy

What does generative AI mean for health care? We asked experts

NIH tests clinical research in primary care with $30 million program

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

UHS says company favors patients whose insurance pays more

Medical leaders decry Supreme Court decision on affirmative action

Study: Why relieving medical debt did not improve financial outcomes

focus

Biden warns of ‘dark winter’ during final presidental debate

Medical device trials still don't enroll enough women, study finds

Readers discuss the intersection of pregnancy and addiction

Curing rare childhood diseases will falter unless Congress steps up

UHS says company favors patients whose insurance pays more

What causes rare myocarditis in young men after Covid vaccines?

hotspot

knowledge

focus

hotspot